Importantly, previous studies have shown that elevated expression of upregulated genes in the E2F1 and E2F2 signature genes are associated with decreased time to distant metastasis free survival in breast cancer patients compared to those with low expression of these genes[21, 38, 40]. The gene discussed is E2F2; the disease is breast cancer.